Conflict of Interest

Jennifer Doudna Disclosures

The Regents of the University of California have patents issued and pending for CRISPR technologies on which J.A.D. is an inventor.

J.A.D. is a cofounder of Caribou BiosciencesEditas MedicineScribe TherapeuticsIntellia Therapeutics, and Mammoth Biosciences. J.A.D. is a scientific advisory board member of VertexCaribou BiosciencesIntellia Therapeutics, Scribe TherapeuticsMammoth Biosciences, Algen BiotechnologiesFelix Biosciences, The Column Group, and Inari. J.A.D. is Chief Science Advisor to Sixth Street, a Director at Johnson & Johnson, Altos and Tempus, and has research projects sponsored by BiogenPfizer,  AppleTree Partners, and Roche.